Causes of Uterine Bleeding in HELLP Syndrome
Uterine bleeding in HELLP syndrome is primarily caused by severe thrombocytopenia and coagulopathy, with the degree of bleeding directly correlating to platelet counts below 40,000/µL, and in severe cases, disseminated intravascular coagulation (DIC) with hyperfibrinolysis. 1
Primary Mechanisms of Hemorrhage
The hemorrhagic complications in HELLP syndrome arise from multiple overlapping pathophysiological processes:
Thrombocytopenia-Related Bleeding
- Platelet consumption occurs due to thrombotic microangiopathy with platelet-fibrin thrombi forming in microvessels 2
- The critical threshold is ≤40,000/µL - patients with intrapartum platelet counts above this level are unlikely to have clinically significant postpartum bleeding, while those below face substantial hemorrhagic risk 3
- The degree of thrombocytopenia correlates directly with the severity of liver dysfunction 4
Coagulopathy Mechanisms
- DIC develops in approximately 50% of HELLP cases, with activated coagulation factors and platelets precipitating disseminated intravascular coagulation 2
- In a minority of cases, this becomes uncompensated DIC contributing to life-threatening hemorrhage 2
- Fulminant hyperfibrinolysis can develop rapidly in the context of DIC, causing diffuse bleeding without isolated sources 5
- Hepatic failure from periportal necrosis reduces synthesis of clotting factors, further worsening coagulopathy 1
Microangiopathic Hemolysis
While not directly causing uterine bleeding, hemolysis contributes to anemia that compounds the clinical picture. The hemolysis occurs in affected microvessels due to the thrombotic microangiopathy 2. A critical pitfall is differentiating between rapid hemoglobin drops from hemolysis versus actual hemorrhage - this distinction can be challenging but is essential for appropriate management 5.
Specific Hemorrhagic Complications
Hemorrhage is a major concern in HELLP syndrome, manifesting as 1:
- Postpartum uterine hemorrhage
- Incisional bleeding (abdominal or vaginal delivery sites) - directly related to degree of thrombocytopenia 3
- Diffuse bleeding from coagulopathy without significant isolated sources 5
- Abdominal wall and cavity hematomas 5
Clinical Predictors and Risk Stratification
Class 1 HELLP (platelets ≤50,000/µL) has significantly higher incidence of postpartum hemorrhagic complications compared to Class 2 (platelets >50,000 but ≤100,000/µL) 3. The antepartum threshold platelet count most predictive of subsequent postpartum hemorrhagic complications is ≤40,000/µL 3.
Important Caveats
- Prophylactic platelet transfusion at delivery does NOT significantly decrease the incidence of postpartum hemorrhagic complications or hasten normalization of postpartum platelet counts 3
- Bleeding relates to multiple factors beyond platelet count alone, including coagulation factor deficiencies, endothelial dysfunction, and the inflammatory cascade 3, 2
- Coagulation tests and platelet counts should be repeated if clinical presentation changes, as the condition can deteriorate rapidly 6
- Consider hemophagocytic syndrome in patients with prolonged hemocytopenia and thrombocytopenia not responding to typical HELLP management 6